$ARCC

These 2 High-Yield Stocks Could Thrive If the Fed Starts Hiking Rates Again

Ares Capital (ARCC) and Main Street Capital (MAIN) reported low non-accrual loans and strong earnings, positioning them for potential Fed rate hikes. ARCC's non-accruals were 2.4% of amortized cost, below the median, and it maintains $6B in liquidity. MAIN's non-accruals were 1.1% at fair value, and its NAV rose to $33.92 per share. Both offer high yields, near 10% for ARCC and high single digits for MAIN.

Original reporting
Published Aug 21, 2026, 5:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 6:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
These 2 High-Yield Stocks Could Thrive If the Fed Starts Hiking Rates Again — source image
Decision brief

The 30-second read

$ARCCNeutralLow
01

Why it matters

Both firms appear financially resilient, positioning them as attractive high‑yield options if the Federal Reserve resumes rate hikes.

02

Market read

Provides a snapshot of credit quality and yield potential for two major BDCs, useful for yield‑focused investors.

03

What to watch

Potential impact of slowing deal flow on future loan origination volumes.

Relevance 4/10Novelty 2/10Timing: post‑quarter report

Background

The article reviews recent quarterly metrics for two large business development companies, Ares Capital (ARCC) and Main Street Capital (MAIN), emphasizing their low non‑accrual rates and dividend coverage.

Company-level read

Ticker impact

$ARCCNeutralMedium confidence
Context

Ares Capital reported non‑accrual loans at 2.4% of amortized cost and $0.47 core earnings per share for the quarter.

Expected impact

Modest upside potential if Fed hikes increase floating‑rate income.

Evidence & confidence

Low non‑accruals and strong liquidity support dividend coverage, making the stock attractive in a higher‑rate environment.

$MAINNeutralMedium confidence
Context

Main Street Capital posted 1.1% fair‑value non‑accruals and $1.04 distributable net investment income per share for the quarter.

Expected impact

Potential modest price appreciation if investors seek high‑yield BDCs amid rate hikes.

Evidence & confidence

Low non‑accrual rate and rising NAV indicate durability, supporting the stock in a rising‑rate scenario.

Market effects

Highlights resilience of high‑yield BDCs, may attract yield‑seeking investors if rates rise.

U.S. BDC sector could see modest inflows.

Limited to investors focused on U.S. high‑yield credit.

Counterpoint

If rate hikes increase borrower stress, BDC credit quality could deteriorate faster than indicated.

Key entities

  • Ares Capital

    Largest publicly traded BDC by net assets.

  • Main Street Capital

    Mid‑market BDC focusing on debt and equity investments.

Related articles

$ARCCMed

Ares Leads $2.2 Billion Healthcare Loan

Ares Management Corp. is leading a $2.2 billion loan to MedImpact Holding Inc. to finance its acquisition of Medical Card System, Inc. The second-lien loan may pay at least 8% over the baseline rate. Ares manages $671 billion in assets and recently reported $708 billion in non-accruing loans. MedImpact serves 20 million customers and processes $40 billion in pharmacy transactions annually.

$PRGMed

Q2 Rundown: PROG (NYSE:PRG) Vs Other Specialty Finance Stocks

Encore Capital Group (PRG) reported Q2 revenue of $491.9M, up 11.3% YoY, beating estimates. HASI reported $36.32M, down 64.9% YoY, missing estimates. TSLX reported $97.84M, down 14.9% YoY, beating estimates. MAIN reported $149.6M, up 3.9% YoY, topping estimates. PRG stock is up 10.4%, HASI up 8.1%, TSLX up 3.1%, and MAIN up 2.5% since reporting.

$MAINMedAI 8/10

Main Street Capital (MAIN) Q2 2026 Earnings Call Transcript

Main Street Capital (MAIN) reported Q2 2026 results on an earnings call. Total investment income was $149.6 million, up 3.9% YoY. Distributable net investment income before taxes was $1.08 per share. NAV rose to $33.92 per share. Management guided Q3 DNII before taxes of at least $0.97 and discussed liquidity, portfolio exits, and supplemental dividends.

$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.

$MAINMed

Main Street Capital (NYSE:MAIN) Posts Better

Main Street Capital (NYSE:MAIN) reported Q2 CY2026 results. Revenue rose 3.9% year on year to $149.6 million, exceeding market expectations by 2.7%, according to the article. Non-GAAP profit was $1.04 per share, 8.7% above analysts’ consensus. The stock was flat at $57.21 after the results.

$MAINMedAI 8/10

MAIN STREET ANNOUNCES SECOND QUARTER 2026 RESULTS

Main Street Capital Corporation (NYSE: MAIN) reported second-quarter 2026 results for the quarter ended June 30, 2026. Net investment income was $90.3 million, or $0.97 per share, and distributable NII was $97.4 million, or $1.04 per share. Net asset value rose to $33.92 per share. The company declared $0.795 per share regular dividends plus a $0.30 supplemental dividend.